Financials
- Market Capitalization 134.51 M
- Employee 61
- Founded 1996
- CEO N/A
- Website www.acumenpharm.com
- Headquarter Delaware, United States
- FIGI BBG0058YJ317
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.05
Fiyat/satışlar oranı
638.93
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3715 | RNA Atrium Therapeutics, Inc. - Common Stock | 7.91 USD | -3.65% | -0.88% | -23.72% | -88.75% | 135.31 M USD | ||
| 3730 | VYGR Voyager Therapeutics, Inc. - Common Stock | 2.19 USD | -3.52% | -11.34% | -30.91% | -52.90% | 134.94 M USD | ||
| 3734 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.56 USD | -5.08% | -5.08% | -13.85% | +35.76% | 136.33 M USD | ||
| 3742 | KRRO Korro Bio, Inc. - Common Stock | 8.69 USD | -7.26% | -11.05% | -36.06% | -77.66% | 127.97 M USD |